EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitLeitlinieOpen Access · CC BY-NC-ND 4.0

International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas

Takao Ohtsuka, Carlos Fernandez-Del Castillo, Toru Furukawa, Susumu Hijioka, Jin-Young Jang, Anne Marie Lennon, Yoshihiro Miyasaka, Eizaburo Ohno, Roberto Salvia, Christopher L Wolfgang, Laura D Wood

Pancreatology · 2024-03 · 24 (2) · 255-270

DOI: 10.1016/j.pan.2023.12.009 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pancreatology, 2024-03. Verfasst von Takao Ohtsuka und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Digestive Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan. Electronic address: takao-o@…. Hauptthemen laut MEDLINE: Pancreatic Intraductal Neoplasms, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 543-mal zitiert (Crossref) und nennt 188 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study group aimed to revise the 2017 international consensus guidelines for the management of intraductal papillary mucinous neoplasm (IPMN) of the pancreas, and mainly focused on five topics; the revision of high-risk stigmata (HRS) and worrisome features (WF), surveillance of non-resected IPMN, surveillance after resection of IPMN, revision of pathological aspects, and investigation of molecular markers in cyst fluid. A new development from the prior guidelines is that systematic reviews were performed for each one of these topics, and published separately to provide evidence-based recommendations. One of the highlights of these new "evidence-based guidelines" is to propose a new management algorithm, and one major revision is to include into the assessment of HRS and WF the imaging findings from endoscopic ultrasound (EUS) and the results of cytological analysis from EUS-guided fine needle aspiration technique, when this is performed. Another key element of the current guidelines is to clarify whether lifetime surveillance for small IPMNs is required, and recommends two options, "stop surveillance" or "continue surveillance for possible development of concomitant pancreatic ductal adenocarcinoma", for small unchanged BD-IPMN after 5 years surveillance. Several other points are also discussed, including identifying high-risk features for recurrence in patients who underwent resection of non-invasive IPMN with negative surgical margin, summaries of the recent observations in the pathology of IPMN. In addition, the emerging role of cyst fluid markers that can aid in distinguishing IPMN from other pancreatic cysts and identify those IPMNs that harbor high-grade dysplasia or invasive carcinoma is discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic Intraductal NeoplasmsPancreatic NeoplasmsCarcinoma, Pancreatic DuctalHumansPancreasEndosonography

Stichwörter der Autor:innen

GuidelinesInternational Association of PancreatologyIntraductal papillary mucinous neoplasmPancreatic cancerSurveillance

Autor:innen und Institutionen

  • Department of Digestive Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan. Electronic address: takao-o@kufm.kagoshima-u.ac.jp.
  • Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: cfernandez@mgh.harvard.edu.
  • Department of Investigative Pathology, Graduate School of Medicine, Tohoku University, Sendai, Japan.
  • Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Division of Hepatobiliary-Pancreatic Surgery, Departments of Surgery, Seoul National University College of Medicine, Seoul, South Korea.
  • Division of Gastroenterology and Hepatology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA.

Zitieren

APA

Ohtsuka, T., Fernandez-Del Castillo, C., Furukawa, T., Hijioka, S., Jang, J. Y., Lennon, A. M., Miyasaka, Y., Ohno, E., Salvia, R., Wolfgang, C. L., & Wood, L. D. (2024). International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas. Pancreatology, 24(2), 255-270. https://doi.org/10.1016/j.pan.2023.12.009

Vancouver

Ohtsuka T, Fernandez-Del Castillo C, Furukawa T, Hijioka S, Jang JY, Lennon AM, et al. International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas. Pancreatology. 2024;24(2):255-270. doi:10.1016/j.pan.2023.12.009

BibTeX
@article{Ohtsuka2024,
  author = {Ohtsuka, Takao and Fernandez-Del Castillo, Carlos and Furukawa, Toru and Hijioka, Susumu and Jang, Jin-Young and Lennon, Anne Marie and Miyasaka, Yoshihiro and Ohno, Eizaburo and Salvia, Roberto and Wolfgang, Christopher L and Wood, Laura D},
  title = {International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas},
  journal = {Pancreatology},
  year = {2024},
  volume = {24},
  number = {2},
  pages = {255--270},
  doi = {10.1016/j.pan.2023.12.009}
}
Kostenlos starten →